GGrantIndex
Sort

40,608 grants matching prostate cancer

Instrumental Variable Methods for Censored Cost Data and an Application in Prosta

$415,371
Anirban Basu · University Of Washington · R01 · FY2013 · CA

Metabolic implications of radiation response in oligometastatic prostate cancer.

$415,367
Nicole L Simone · University Of Maryland Baltimore · U54 · FY2024 · CA

ENDOTHELIN 1 INDUCED PAIN AND METASTATIC PROSTATE CANCER

$415,310
Brigham And Women'S Hospital · R01 · FY2002 · CA

The role of focal adhesion kinase in therapy resistant prostate tumors

$415,276
Jiaoti Huang · Duke University · R01 · FY2024 · CA

Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium

$415,242
Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2010 · CA

Baby bottles that release no chemicals having estrogenic activity

$415,197
Yantian Wang · Plastipure, Inc. · R44 · FY2012 · ES

A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression

$415,155
William Nathaniel Brennen · Johns Hopkins University · R01 · FY2022 · CA

A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression

$415,155
William Nathaniel Brennen · Johns Hopkins University · R01 · FY2025 · CA

Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor

$415,154
Bruce R Zetter · Boston Children'S Hospital · R01 · FY2017 · CA

Biology of Non-Coding RNAs Associated with Psychiatric Disorders

$415,143
Daniel B. Campbell · University Of Southern California · R01 · FY2014 · MH

Developing knowledge models to enable rapid learning in radiation therapy

$415,140
Qingrong Jackie Wu · Duke University · R01 · FY2019 · CA

SOUTHWEST ONCOLOGY GROUP CA-13612

$415,058
University Of Arizona · U10 · FY2000 · CA

QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS

$415,058
Joseph A O'Sullivan · Washington University · R01 · FY2021 · CA

The Role of Fgf Signaling in Vertebrate Development

$415,028
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening

$414,889
Judith Mary Eileen Walsh · University Of California, San Francisco · R01 · FY2016 · CA

Engineering and Evaluation of Human L-Methionase for Cancer Therapy

$414,813
George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2014 · CA

Epigenotyping in Peripheral Blood Cell DNA and Risk of Breast Cancer

$414,801
Susan R Sturgeon · University Of Massachusetts Amherst · R15 · FY2013 · CA

Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma pheochromocytoa

$414,789
Frank Lin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

The urinary microbiome and bladder toxicity after pelvic radiotherapy

$414,781
Brian Marples · University Of Rochester · R21 · FY2024 · CA

CDK inhibitors in tumor progression

$414,775
Andrew Koff · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA

Project 1: The biochemical, topological and functional impact of cancer associated Ctcfmutations and their contribution to cancer

$414,691
Jane Amanda Skok · New York University School Of Medicine · P01 · FY2021 · CA

Administrative Core

$414,648
Brian E Henderson · University Of Southern California · U19 · FY2013 · CA

Community Outreach and Engagement

$414,637
Lourdes Baezconde Garbanati · University Of Southern California · P30 · FY2022 · CA

Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy

$414,585
Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2023 · CA

Recombinational Mechanisms of DNA Repair

$414,575
Wolf-Dietrich Heyer · University Of California At Davis · R01 · FY2024 · GM